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A B S T R A C T
Objective: The impact of systemic inﬂammation on clinical outcomes after CABG surgery is still
controversial. In this study, we evaluated the impact of the markers of inﬂammation, endothelial damage
and platelet activation on clinical outcomes after on- and off-pump CABG.
Methods: A group of 191 consecutive on- and off-pump CABG patients were prospectively studied. Blood
samples were drawn before surgery, 18–36 h after the procedure and 5–7 days postoperatively and
analyzed for 8-iso-prostaglandin F2a (8-iso-PGF2a), asymmetric dimethylarginine (ADMA) and b-
thromboglobulin (b-TG). White blood count and C-reactive protein were measured twice, ﬁrst before
and then during the ﬁrst 18–36 h after CABG. The primary clinical end-points were: low cardiac output
syndrome (LCOS), postoperative myocardial infarction (PMI) and in-hospital cardiovascular death.
Results: Elevation of 8-iso-PGF2a, ADMA and b-TG before surgery was associated with an increased risk
of morbidity and mortality after CABG. There were no differences in analyzed markers and clinical
outcomes between the on- and off-pump groups. Even during the uncomplicated postoperative course
the inﬂammatory response was enhanced and still remained higher than baseline 5–7 days after surgery.
Conclusion: Links between preoperative 8-iso-PGF2a, ADMA and b-TG and unfavorable early post-CABG
outcomes suggest that these markers could be useful in identifying patients with increased risk of LCOS,
PMI and in-hospital cardiovascular death following elective CABG.
 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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jo u rn al h om epag e: ww w.els evier .c o m/lo cat e/ ih jWhat is already known?
 The inﬂuence of systemic inﬂammatory markers on clinical
outcomes after CABG surgery remains a matter of scientiﬁc
debate.
What this study adds?
 High levels of inﬂammatory markers before surgery could be
helpful in prediction of unfavorable early post-CABG clinical
outcomes. This study also conﬁrms the concept that CABG is* Corresponding author at: John Paul II Hospital, 80 Pra˛dnicka St., 31-202 Krako´w,
Poland.
E-mail address: plicner@pro.onet.pl (D. Plicner).
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0019-4832/ 2016 Published by Elsevier B.V. on behalf of Cardiological Society of
creativecommons.org/licenses/by-nc-nd/4.0/).associated with systemic inﬂammatory response regardless of
the use of CPB.
1. Introduction
Systemic inﬂammatory response together with microemboli-
zation is responsible for most of the morbidity after on-pump
coronary artery bypass graft surgery (CABG). In spite of improve-
ments in anesthesia as well as surgical techniques, CABG is still
associated with enhanced inﬂammation.1 To reduce these effects,
reintroduction of off-pump coronary artery bypass surgery
(OPCAB) has become increasingly more common in recent years.2
The inﬂuence of OPCAB on reduction of systemic inﬂammation
remains a matter of scientiﬁc debate. A small number of trials have
correlated the biochemical ﬁndings of systemic inﬂammation with
the clinical outcomes of patients after CABG.2–5s of inﬂammatory markers predict clinical outcomes in patients
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CABG and OPCAB regarding: (1) oxidative stress, (2) endothelial
cells, (3) platelets, (4) C-reactive protein (CRP) and (5) white blood
count (WBC).
Oxidative stress is caused by an imbalance between free radical
generation and elimination. Evidence indicates that oxidative
stress contributes to myocardial ischemia-reperfusion injury.6 8-
iso-prostaglandin F2a (8-iso-PGF2a) was analyzed as a marker of
oxidative stress.7
By the production of various substances, the vascular endothe-
lium is a signiﬁcant regulator of cardiovascular function. Nitric
oxide (NO) is produced in endothelial cells and plays an important
role in various cardioprotective effects including: inhibition of
superoxide radicals and inhibition of platelet activation.8 Oxidative
stress during myocardial reperfusion after cardiac surgery reduces
the bioavailability of NO. For the assessment of endothelial injury
we chose asymmetric dimethylarginine (ADMA) as a natural
inhibitor of NO synthase.9,10
A variety of agonists secreted by platelets and other cells
contribute to activation of platelets during surgery. Platelet
secreted cytokines may be involved in the inﬂammatory response
to coronary surgery because of the strong activation of platelets.11
b-thromboglobulin (b-TG) stands for a group of platelet proteins,
which are released in large amounts subsequent to platelet
activation.12
Therefore, in this study we evaluated the inﬂuence of
cardiopulmonary bypass (CPB) on systemic inﬂammatory re-
sponse, endothelial damage and platelet activation. In addition, we
correlated the pre- as well as postoperative values of inﬂammatory
markers with the clinical outcomes after CABG surgery.
2. Materials and methods
Study protocol was approved by the local Research Ethics Board
and all participating patients signed an informed consent. The
study was performed in accordance with the Declaration of
Helsinki and with the consensus guidelines expressed by the
STROBE statement.
2.1. Patients
The study was compromised of 191 consecutively recruited
patients undergoing isolated, elective on- or off-pump CABG
procedure between January and March 2008. Indications for CABG
were consistent with the European Society of Cardiology and the
European Association for Cardio-Thoracic Surgery guidelines on
myocardial revascularization.13 Exclusion criteria were history of
previous cardiac surgery, or percutaneous coronary intervention
(PCI) within 1 month prior to surgery, renal insufﬁciency and liver
dysfunction. All data was collected prospectively. The primary
clinical endpoints were low cardiac output syndrome (LCOS)
without postoperative myocardial infarction (PMI), PMI and in-
hospital cardiovascular death.
LCOS was diagnosed if the patient required an intra-aortic
balloon pump to be weaned from CPB or because of hemodynamic
compromise while in the intensive care unit (ICU). LCOS was also
diagnosed if the patient required inotropic therapy (dopamine,
dobutamine, milnirone, or epinephrine) to maintain the systolic
blood pressure >90 mm Hg and cardiac output >2.2 L/min/m2 for
30 min in the ICU, after correction of all of the electrolyte and
blood gas abnormalities and after adjusting the preload and
afterload to its optimal value. Patients who received a low dose of
dopamine (3 mg/kg/min) were not considered to have LCOS.
Patients who required vasoconstricting medications because of a
high cardiac output (2.5 L/min/m2) and low peripheral resistance
were also not considered to have LCOS.14Please cite this article in press as: Plicner D, et al. Preoperative value
after CABG, regardless of the use of cardiopulmonary bypass, IndianPMI was deﬁned as a serum creatine kinase-myocardial band
(CK-MB) value 5 times greater than the upper limit of normal
(>85 U/L) with new Q waves present, or a CK-MB level 10 times
greater than the upper limit of normal (<170 U/L), (with or without
Q waves), or new regional wall motion abnormalities demonstrat-
ed by transesophageal echocardiography.15
In-hospital cardiovascular death was deﬁned as death occurring
during the same hospitalization period as the CABG surgery due to
heart failure, PMI, stroke, cardiovascular hemorrhage or sudden
cardiac death.
2.2. CABG procedure
All patients underwent standardized anesthesia. CABG was
carried out through median sternotomy. All patients were
operated on by consecutive surgeons according to their own
preference, including use of CPB and the type of cardioplegia. CPB
was carried out with a 40 mm arterial blood ﬁlter (Jostra
Medizintechnik AG, Hirrlingen, Germany) and a nonpulsatile
roller pump (Jostra Medizintechnik AG, Hirrlingen, Germany).
Besides heparin coated CPB circuit we did not make any special
measures to reduce inﬂammation during surgery. Mean arterial
pressure was maintained between 40 and 60 mm Hg and blood
ﬂow was kept at 2.0–2.4 L/min per m2. Moderate systemic
hypothermia (esophageal temperature, 32–34 8C) was applied.
Myocardial preservation was achieved with aortic root infusion of
intermittent warm blood or cold crystalloid cardioplegia, accord-
ing to the surgeon’s preference. Anticoagulation was achieved by
administration of heparin (500 IU/kg) before the onset of CPB and
was monitored by means of the activated clotting time (>400 s).
After all anastomoses were completed, anticoagulation was
reversed by protamine chloride to a normal activated clotting
time. All patients received standardized postoperative care.
OPCAB procedures were performed by the same heparinization
protocol as described above. The revascularization in the OPCAB
patients was performed on the beating heart using the Octopus IV
system (Medtronic Inc., Minneapolis, USA) and a coronary ﬂow-
shunt was always passed into the coronary arteriotomy.
2.3. Laboratory investigations
Blood samples were drawn from an anticubital vein with
minimal stasis after an overnight fast, before the start of any
anesthesia and surgery procedures, 18–36 h after the procedure
and 5–7 days postoperatively and analyzed for 8-iso-PGF2a, ADMA
and b-TG. Commercially available enzyme-linked immuno sorbent
assays were used to measure plasma 8-iso-PGF2a (Cayman
Chemicals, Ann Arbor, MI) and plasma b-TG (Diagnostica Stago,
Asnieres, France). ADMA measurement was performed by isocratic
high-performance liquid chromatography as described by Teerlink
et al.16 Routine laboratory variables, including blood cell count,
CRP and myocardial necrosis markers, were determined using
standard laboratory techniques. WBC and CRP were measured
preoperatively and 18–36 h after CABG. Normal values of WBC and
CRP were 3.8–10.0  109/L and below 5 mg/L respectively. CK-MB
values were measured at 6, 12, 18, and 24 h after surgery. The CK-
MB level of 17 U/L was considered the upper normal value. All
measurements were performed by technicians blinded to the
origin of the samples. Intra- and inter-assay coefﬁcients of
variation were <7%.
2.4. Statistical analysis
Continuous variables were presented as mean and standard
deviation () or as median with 25th, 75th percentiles inter-quartile
range (IQR) as it concerned postoperative drainage and CRP.s of inﬂammatory markers predict clinical outcomes in patients
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The Shapiro–Wilk test was used to test the normality of continuous
variables. In order to examine the differences between the two
independent groups, Student’s t-test (for continuous normally
distributed variables) or the Mann–Whitney U-test (for non-normally
distributed variables) were used. The x2 test or Fisher’s exact test
were used to compare distributions of categorical variables between
independent groups. To assess the linear correlation between
variables, the Pearson correlation coefﬁcient for normally distributed
variables or Spearman’s rank correlation coefﬁcient for non-normally
distributed variables were calculated. The association between the 8-
iso-PGF2a, ADMA, b-TG, WBC, CRP levels and LCOS, PMI or in-hospital
death was evaluated by logistic regression analysis. No multivariate
logistic regression modeling was performed owing to a low number of
LCOS events (13 cases), PMI events (19 cases) and in-hospital deaths
(7 cases). Statistical analysis was performed with Statistica 10.0
(StatSoft, Tulsa, OK, USA). Two-sided p-values of <0.05 were
considered statistically signiﬁcant.
3. Results
3.1. Peri- and postoperative data
Table 1 shows patient’s demographic data. Baseline variables
such as age, gender, risk factors for coronary artery disease,
preoperative ejection fraction, EuroSCORE I and medications were
comparable among groups. 158 patients underwent on-pump
CABG and 33 were operated without CPB. The groups did not differ
in terms of total transfusion as well as LCOS, PMI, ICU length of stay
and in-hospital death, whereas postoperative drainage was slightly
higher for patients with CPB (Table 2). Mean baseline values of
studied parameters are shown in Table 3.
In all patients 8-iso-PGF2a increased by 30% at 18–36 h post-
CABG (p = 0.05) and then decreased by 11% 5–7-days after surgery
(p < 0.0001). Similarly, ADMA increased by 70% 18–36 h after
CABG (p = 0.0001) and then decreased by 21% in 5–7 postoperative
days (p = 0.0001). b-TG increased by 44% 18–36 h post-CABG
(p < 0.001) and decreased by 19% 5–7days after the procedure
(p = 0.001) (Table 3). There was a positive correlation between
ADMA and 8-iso-PGF2a at all-time points (r = 0.71 at baseline,
r = 0.73 at 18–36 h and r = 0.70 in 5–7 postoperative days,
p < 0.001 for all comparisons) and between b-TG and 8-iso-PGF2a
(r = 0.62 at baseline, r = 0.68 at 18–36 h and r = 0.61 in 5–7Table 1
Baseline characteristics of CABG patients.
Variable All patients n = 191 Pati
Age (years) 64.9  8.1 65.2
Female, n (%) 43 (22.5) 35 (
Peripheral vascular disease, n (%) 31 (16.2) 25 (
Diabetes mellitus, n (%) 59 (30.9) 46 (
Insulin, n (%) 28 (14.7) 22 (
Hypertension, n (%) 158 (82.7) 127
Hypercholesterolemia, n (%) 126 (66.0) 101
Previous myocardial infarction, n (%) 154 (80.6) 128
Previous PCI, n (%) 23 (12.0) 19 (
Current smoking, n (%) 54 (34.2) 44 (
COPD, n (%) 11 (5.8) 9 (5
Atrial ﬁbrillation, n (%) 11 (6.8) 10 (
BMI, kg/m2 28.0  3.9 28.0
LVEF, % 52.0  9.3 52.1
EuroSCORE I 2.9  1.9 3.0 
Aspirin, n (%) 38 (20.1) 31 (
ACE inhibitors, n (%) 168 (88.0) 137
b-blockers, n (%) 172 (90.1) 141
Lipid-lowering statin, n (%) 171 (89.5) 141
Values are displayed as mean  standard deviation or number (percentage).
ACE, angiotensin-converting enzyme; BMI, body mass index; COPD, chronic obstructive pu
interventions.
Please cite this article in press as: Plicner D, et al. Preoperative value
after CABG, regardless of the use of cardiopulmonary bypass, Indianpostoperative days, p < 0.001 for all comparisons). WBC increased
by 45% and CRP increased by 6320% 18–36 h after CABG
(p = 0.016 and p = 0.024 respectively) (Table 3). No differences,
in terms of analyzed markers, were noted for the different types of
CABG (on-pump CABG versus OPCAB) (Fig. 1). There were no
correlations between postoperative 8-iso-PGF2a, ADMA, b-TG,
WBC or CRP and cross-clamp time or CPB time.
3.2. Low cardiac output syndrome without postoperative myocardial
infarction
Of the 191 patients, 6.8% developed LCOS without PMI, 6.3%
patients from the on-pump CABG group and 9.1% from the
OPCABG patients (p = 0.567) (Table 2). There were no differences
in the baseline demographic or clinical variables between the
LCOS subgroup and remaining subjects (data not shown). All
studied parameters before CABG, except for the baseline CRP,
were statistically higher in patients with LCOS (Table 3).
Postoperative values of analyzed markers were signiﬁcantly
higher in the LCOS subgroup, regardless of the use of CPB.
Regression analysis showed a signiﬁcant correlation between
preoperative 8-iso-PGF2a, ADMA and b-TG levels, and LCOS
(p = 0.024, p = 0.017 and p = 0.021 respectively).
3.3. Postoperative myocardial infarction
9.9% patients developed PMI, 8.2% patients from the on-pump
CABG group and 18.2% from the OPCABG group (p = 0.082)
(Table 2). There were no signiﬁcant differences between the PMI
patients and the remaining subjects with regard to demographic
data (data not shown). Baseline 8-iso-PGF2a, ADMA and b-TG
levels were signiﬁcantly higher in the PMI subgroup (Table 3).
After surgery, all analyzed markers were statistically higher in the
PMI subgroup, irrespective of use of CPB. Regression analysis
showed a signiﬁcant correlation between preoperative 8-iso-
PGF2a, ADMA and b-TG levels, and PMI (p = 0.045, p = 0.012 and
p = 0.001 respectively).
3.4. In-hospital cardiovascular death
3.7% patients died during the early postoperative period due to
extensive PMI. These were 3.8% patients from the on-pump CABG
group and 3.0% from the OPCABG group (p = 0.831), (Table 2).ents with CPB n = 158 Patients without CPB n = 33 p
  8.2 63.5  7.4 0.282
22.2) 8 (24.2) 0.794
15.8) 6 (18.2) 0.738
29.1) 13 (39.4) 0.245
13.9) 6 (18.2) 0.529
 (80.4) 31 (93.9) 0.061
 (63.9) 25 (75.8) 0.192
 (81.0) 26 (78.8) 0.769
12.0) 4 (12.1) 0.998
32.6) 10 (43.5) 0.309
.7) 2 (6.1) 0.942
7.2) 1 (4.3) 0.610
  3.9 28.0  4.0 0.791
  9.4 51.3  9.2 0.648
 1.9 2.6  2.0 0.329
19.9) 7 (21.2) 0.862
 (86.7) 31 (93.9) 0.246
 (89.2) 31 (93.9) 0.412
 (89.2) 30 (90.9) 0.776
lmonary disease; LVEF, left ventricular ejection fraction; PCI, percutaneous coronary
s of inﬂammatory markers predict clinical outcomes in patients
 Heart J. (2016), http://dx.doi.org/10.1016/j.ihj.2016.10.002
Table 2
Operative and postoperative characteristics of CABG patients.
Variable All patients n = 191 Patients with CPB n = 158 Patients without CPB n = 33 p
Aortic cross-clamp time, minutes 40.1  14.0 40.1  14.0 – –
CPB time, minutes 89.2  32.2 89.2  32.2 – –
Transfusion (red cells/platelets/plasma) 2 units, n (%) 126 (66) 105 (66.5) 21 (63.6) 0.137
Postoperative drainage, mL 700 (480–975) 850 (540–1150) 685 (480–920) 0.017
LCOS, n (%) 13 (6.8) 10 (6.3) 3 (9.1) 0.567
PMI, n (%) 19 (9.9) 13 (8.2) 6 (18.2) 0.082
ICU length of stay 2 days, n (%) 82 (43.2) 62 (39.2) 20 (62.5) 0.511
In-hospital cardiovascular death, n (%) 7 (3.7) 6 (3.8) 1 (3.0) 0.831
Values are displayed as mean  standard deviation, number (percentage) or median with 25th–75th percentiles inter-quartile range.
CPB, cardiopulmonary bypass; ICU, intensive care unit; LCOS, low cardiac output syndrome; PMI, postoperative myocardial infarction.
Table 3
Changes of studied inﬂammatory response parameters in patients with analyzed clinical end-points.
Variable All patients
n = 191
Patients with
LCOS n = 13
Patients
without
LCOS n = 178
p Patients with
PMI n = 19
Patients
without
PMI n = 172
p In-hospital
death n = 7
Survivors
n = 184
p
Baseline 8-iso-PGF2a, (pg/mL) 358.6  39.3 392.1  56.2 356.1  36.8 0.001 386.5  52.5 355.5  36.5 <0.001 385.8  53.9 357.0  38.1 0.011
18–36 h post
CABG 8-iso-PGF2a, (pg/mL)
468.1  43.4 526.2  75.1 463.4  36.4 0.015 505.3  66.4 463.4  37.4 0.017 543.4  50.2 464.7  40.4 0.021
5–7 days post
CABG 8-iso-PGF2a, (pg/mL)
417.0  48.2 528.9  58.9 409.3  36.8 0.001 500.7  70.7 409.5  37.9 0.005 549.3  10.6 412.2  43.2 0.004
Baseline ADMA, (mmol/L) 0.56  0.06 0.65  0.08 0.56  0.05 0.001 0.64  0.09 0.55  0.09 <0.001 0.62  0.11 0.56  0.06 0.041
18–36 h post
CABG ADMA, (mmol/L)
0.95  0.10 1.13  0.17 0.93  0.09 0.002 1.06  0.16 0.93  0.08 0.002 1.17  0.14 0.93  0.10 0.031
5–7 days post CABG ADMA,
(mmol/L)
0.75  0.12 1.04  0.12 0.73  0.09 <0.001 0.96  0.15 0.73  0.10 0.002 1.10  0.06 0.74  0.10 0.003
Baseline b-TG, (IU/mL) 58.8  10.0 70.4  12.6 56.9  9.2 0.002 68.2  12.5 56.7  9.1 <0.001 64.8  15.3 57.5  9.7 0.025
18–36 h post CABG b-TG,
(IU/mL)
84.6  21.5 109.3  28.2 82.6  19.7 0.007 100.4  26.9 82.6  20.0 <0.001 108.0  24.2 83.5  20.7 <0.001
5–7 days post CABG b-TG,
(IU/mL)
68.5  17.3 107.6  16.7 65.8  13.8 <0.001 94.9  24.1 66.1  14.5 0.006 114.0  15.0 66.7  14.7 0.005
Baseline WBC count, (109/L) 7.3  2.1 8.8  3.9 7.2  1.9 0.009 8.2  3.5 7.2  1.9 0.252 8.2  1.5 7.3  2.2 0.215
18–36 h post
CABG WBC count, (109/L)
10.6  3.9 15.5  7.2 10.1  3.1 0.032 14.1  6.3 10.0  3.1 0.016 15.7  5.9 10.5  3.7 0.039
Baseline CRP, (mg/L) 2.5 (1.5–4.8) 4.0 (1.8–9.1) 2.4 (1.5–4.7) 0.342 3.9 (1.7–8.9) 2.4 (1.5–4.5) 0.748 2.6 (2.4–8.2) 2.4 (1.5–4.7) 0.356
18–36 h post CABG CRP,
(mg/L)
160.5
(125.9–188.5)
180.7
(170.9–258.8)
152.9
(124.0–187.1)
0.009 175.8
(170.6–230.2)
152.8
(123.8–187.5)
0.025 254.8
(201.4–256.2)
153.1
(124.5–186.3)
0.030
Values are displayed as mean  standard deviation or median with 25th–75th percentiles inter-quartile range.
8-iso-PGF2a, 8-iso-prostaglandin F2a; ADMA, asymmetric dimethylarginine; b-TG, b-thromboglobulin; CABG, coronary artery bypass grafting; CPB, cardiopulmonary bypass; CRP,
C-reactive protein; WBC, white blood counts.
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respect to demographic and clinical variables (data not shown).
As in the case of LCOS and PMI, this small subgroup was
characterized by higher 8-iso-PGF2a, ADMA, and b-TG levels at0.1
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p = 0.043 and p = 0.014 respectively).
4. Discussion
We demonstrated for the ﬁrst time in a large number of CABG
patients the simultaneous level changes of 8-iso-PGF2a, ADMA, b-
TG, WBC and CRP. We showed that clinical outcomes in early
postoperative course are associated with these markers of
inﬂammation, oxidative stress and platelet activation. The most
important ﬁnding of our study is that elevation of 8-iso-PGF2a,
ADMA and b-TG before surgery is associated with an increased risk
of morbidity (LCOS and PMI) and mortality after CABG, which
expands our previous observations made in smaller groups of
patients that suggested a prognostic role of these processes in
patients undergoing CABG.17,18 Postoperatively all studied param-
eters, including WBC and CRP, increased statistically higher in
patients with primary clinical endpoints, regardless of use of CPB.
Even during the uncomplicated postoperative course the inﬂam-
matory response was enhanced and still remained higher than
baseline 5–7 days after surgery. On-pump as well as off-pump
surgery were associated with a similar increase of studied markers.
Additionally there was no correlation between analyzed postop-
erative markers and time of CPB or even with aortic cross-clamp
time. Our ﬁndings are consistent with other studies that
demonstrated that cardiac surgery results in extensive oxidative
stress response irrespective of whether CABG was performed with
or without CPB.19,20 In contrast to our results several studies have
shown that with OPCAB, the degree of inﬂammatory response is
signiﬁcantly less expressed.2 Because of the small number of
patients in these trials, no signiﬁcant difference in clinical
outcomes between groups was observed.
We have already reported that oxidative stress, measured by 8-
iso-PGF2a, is associated with ADMA increase after on-pump CABG
and pre-procedure high levels of these markers are associated with
PMI and in-hospital cardiovascular death.17 In this study we
demonstrate that also in OPCAB, baseline ADMA as well as 8-iso-
PGF2a are predictors of unfavorable postoperative outcomes in the
same degree as in on-pump CABG. Also baseline ADMA elevation
cannot be explained by renal dysfunction, as renal insufﬁciency
was an exclusion criterion in this report. These results corroborate
ﬁndings obtained by Karu et al. who observed that cardiac surgery
results in extensive oxidative stress response and a marked
increase in ADMA, regardless of the method or type of surgical
procedure used.19,21
This study demonstrates that the occurrence of LCOS, PMI
and in-hospital death after elective, isolated CABG is also associated
with increased platelet activation, measured by b-TG. We reported
previously that platelet activation and oxidative stress are
signiﬁcantly enhanced in patients undergoing CABG surgery and
preoperative elevated levels of b-TG are associated with an
increased risk of PMI.18 Our current study shows that the activation
of platelets increase to the same degree in on-pump CABG as in
OPCAB and increased level of b-TG at baseline is associated with
unfavorable early postoperative outcomes, including as well PMI,
LCOS and in-hospital cardiovascular death. Moller et al. observed
that platelets after OPCAB were more easily activated in the early
postoperative period than in on-pump CABG.22
Inﬂammatory markers such as CRP and WBC were raised
similarly after on-pump CABG as well as after OPCAB. There are
wide number of studies showing controversial results of inﬂam-
matory markers in comparison of OPCAB versus on pump CABG. As
conﬁrmed in our study, Karu et al. showed that CRP concentrations
still remained higher than baseline by the end of the ﬁrst
postoperative week. This CRP response was irrespective of whether
CABG surgery was performed with or without CPB.19 On the otherPlease cite this article in press as: Plicner D, et al. Preoperative value
after CABG, regardless of the use of cardiopulmonary bypass, Indianhand, Raja et al. published a few studies in which the increases of
CRP levels and WBC were greater and persisted for a longer time
after on-pump CABG with respect to OPCAB.2 Nevertheless in our
study preoperative levels of CRP and WBC were not associated with
any clinical endpoints.
We reported previously that the inﬂammatory response during
cardiac surgery is at least in part related to the genetic
characteristics of any given individual and the candidates are
genes for tumor necrosis factor alpha and interleukin 6 as
evidenced previously.23,24 These ﬁndings are consistent with a
study by Lehmann et al. who also demonstrated a genetic inﬂuence
on systemic inﬂammatory response to CABG.25 In our study,
elevation of 8-iso-PGF2a, ADMA and b-TG before surgery is
associated with an increased risk of morbidity and mortality after
CABG and high baseline levels of these markers are likely of genetic
origin. The data regarding inﬂammatory response to CPB are still
inconsistent. Our ﬁndings suggest that 8-iso-PGF2a, ADMA and b-
TG determined before on-pump CABG as well as OPCAB, could be
helpful in identifying patients at risk of LCOS, PMI and in-hospital
death. In addition, this study validate the concept that other
mechanisms rather than CPB and myocardial ischemia during
aorta cross-clamp are responsible for increased postoperative
inﬂammatory response.
This study has some limitations. The most important limitation
of our study is the lack of control group. Comparison of systemic
inﬂammatory response, endothelial damage and platelet activation
between patients having classical full sternotomy cardiac surgery to
the same surgery performed by minithoracotomy or to the simple
sternotomy in non cardiac surgery could help to answer the
question of how important a role in inﬂammatory response plays
range of surgical trauma. It is a retrospective analysis of
prospectively collected data at a single center. The sample size of
the study group was limited and restricted to CABG patients. 8-iso-
PGF2a, ADMA and b-TG levels were measured only at three time
points. Windows of postoperative measurements were wide. Using
a stricter measurement regimen could also give less variation in the
results. It is probable that measurements performed more often,
especially during the ﬁrst 24 h after the procedure, could provide
new information on the effect of CABG on inﬂammatory response,
endothelial damage and platelet activation markers formation and
elimination. EuroSCORE I values were low as only elective, isolated
CABG patients, without previous history of cardiac surgery and
without renal function impairment were recruited. The results of
this study cannot be extrapolated to high-risk patients. Other
factors such as diet might also affect preoperative levels of the
variables studied especially oxidative stress.26,27 The low incidence
of the primary clinical endpoints may impact the power available
for this study and could introduce unexpected bias into the
outcomes. At last, our study was limited to the hospital stay. It
would be of interest to assess analyzed markers and clinical
endpoints, within the ﬁrst postoperative months.
5. Conclusion
Links between preoperative levels of 8-iso-PGF2a, ADMA and
b-TG and unfavorable early post-CABG outcomes suggest that
these markers could be useful in identifying patients at increased
risk of LCOS, PMI and in-hospital cardiovascular death following
elective surgery. Our results validate the concept that CABG
surgery is associated with systemic inﬂammatory response,
endothelial damage and platelet activation regardless of the
use of CPB.
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